Accurate prediction of protonation state as a prerequisite for reliable MM-PB(GB)SA binding free energy calculations of HIV-1 protease inhibitors.
Article Details
- CitationCopy to clipboard
Wittayanarakul K, Hannongbua S, Feig M
Accurate prediction of protonation state as a prerequisite for reliable MM-PB(GB)SA binding free energy calculations of HIV-1 protease inhibitors.
J Comput Chem. 2008 Apr 15;29(5):673-85.
- PubMed ID
- 17849388 [ View in PubMed]
- Abstract
Binding free energies were calculated for the inhibitors lopinavir, ritonavir, saquinavir, indinavir, amprenavir, and nelfinavir bound to HIV-1 protease. An MMPB/SA-type analysis was applied to conformational samples from 3 ns explicit solvent molecular dynamics simulations of the enzyme-inhibitor complexes. Binding affinities and the sampled conformations of the inhibitor and enzyme were compared between different HIV-1 protease protonation states to find the most likely protonation state of the enzyme in the complex with each of the inhibitors. The resulting set of protonation states leads to good agreement between calculated and experimental binding affinities. Results from the MMPB/SA analysis are compared with an explicit/implicit hybrid scheme and with MMGB/SA methods. It is found that the inclusion of explicit water molecules may offer a slight advantage in reproducing absolute binding free energies while the use of the Generalized Born approximation significantly affects the accuracy of the calculated binding affinities.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Amprenavir Human immunodeficiency virus type 1 protease Protein Human immunodeficiency virus 1 YesInhibitorDetails Indinavir Human immunodeficiency virus type 1 protease Protein Human immunodeficiency virus 1 YesInhibitorDetails Lopinavir Human immunodeficiency virus type 1 protease Protein Human immunodeficiency virus 1 YesInhibitorDetails Nelfinavir HIV-1 protease Protein Human Immunodeficiency Virus YesInhibitorDetails Ritonavir Human immunodeficiency virus type 1 protease Protein Human immunodeficiency virus 1 YesInhibitorDetails Saquinavir Human immunodeficiency virus type 1 protease Protein Human immunodeficiency virus 1 YesInhibitorDetails